Agentic AI represents an opportunity for shared global development as it can become a tool for leapfrogging legacy digital ...

On the evening of July 10, AI investor Matt Shumer posted a terse, furious message to X: GPT-5.6 Sol had just accidentally deleted nearly all the files on his Mac ...

The dumbest device in my homelab is the smartest choice.

Cathie Wood's Ark Genomic Revolution ETF owns $50 million worth of Recursion Pharmaceuticals stock.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Scientists have unveiled a new fabrication technique for the ultra-clean manufacturing of 2D heterostructures—materials just ...

Intactis Bio joins the Biocomputing industry, which seeks to deliver lower-energy, cost-efficient computing capacity driven ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Peptide stacks promise weight loss, muscle growth, and more. But many popular peptides aren’t approved in the U.S.

In 2026, most companies are using AI in some fashion, as companies feel pressure to keep up with competitive industry dynamics and experiment with the new technology. The stocks on this list were ...